| Title |
Comparative Efficacy of Lamivudine and Emtricitabine: A Systematic Review and Meta-Analysis of Randomized Trials
|
|---|---|
| Published in |
PLOS ONE, November 2013
|
| DOI | 10.1371/journal.pone.0079981 |
| Pubmed ID | |
| Authors |
Nathan Ford, Zara Shubber, Andrew Hill, Marco Vitoria, Meg Doherty, Edward J. Mills, Andy Gray |
| Abstract |
Lamivudine and emtricitabine are considered equivalent by several guidelines, but evidence of comparable efficacy is conflicting. |
Mendeley readers
The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Libya | 1 | 1% |
| Netherlands | 1 | 1% |
| Unknown | 74 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 14% |
| Researcher | 10 | 13% |
| Student > Bachelor | 10 | 13% |
| Student > Postgraduate | 8 | 10% |
| Other | 7 | 9% |
| Other | 14 | 18% |
| Unknown | 17 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 38% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 16% |
| Nursing and Health Professions | 3 | 4% |
| Immunology and Microbiology | 3 | 4% |
| Chemistry | 3 | 4% |
| Other | 9 | 12% |
| Unknown | 18 | 23% |